- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA clears ADAC's coincidence detection
Nuclear medicine vendor ADAC Laboratories of Milpitas, CA, gota helping hand from the Food and Drug Administration at this year'sRadiological Society of North America meeting. The agency clearedADAC's 510(k) application for its molecular coincidence
Nuclear medicine vendor ADAC Laboratories of Milpitas, CA, gota helping hand from the Food and Drug Administration at this year'sRadiological Society of North America meeting. The agency clearedADAC's 510(k) application for its molecular coincidence detection(MCD) technique just days before the Chicago conference.
MCD enables nuclear medicine physicians to image high-energyPET radioisotopes like fluorodeoxyglucose without the use of heavycollimators (SCAN 6/21/95). ADAC is bullish on the technology,which it believes will lead to increased applications in nuclearmedicine. The company is sponsoring a multicenter trial startingearly next year to validate the clinical utility of MCD, accordingto Ian Farmer, vice president of marketing.
Several other nuclear medicine vendors are developing coincidencedetection techniques, but ADAC believes it has an 18 to 24-monthlead on its competitors in bringing a product to market, Farmersaid.
In other ADAC news, the company last month acquired JD TechnicalServices of Washington, MO, a gamma camera service and refurbishingfirm. The $1.7 million acquisition enables ADAC to refurbish andsell cameras made by other vendors. The company will also be thecornerstone of ADAC's new multivendor gamma camera service program,according to Farmer (see story, page 5).
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.
